Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silberstein, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silberstein, E. B.

Radiology, Vol 136, 747-751, Copyright © 1980 by Radiological Society of North America

ARTICLES

A radiopharmaceutical and clinical comparison of 99mTc-Sn- hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate

EB Silberstein

A comparison of 99mTc labeled hydroxyethylidene diphosphonate (99mTc- HEDP) and hydroxymethylene diphosphonate (99mTc-HMDP), two bone scanning agents differing by a single methyl group, was performed in 20 patients. In nine patients, no difference in scan quality was found. Of the other 11, HMDP had significantly better bone delineation (p = 0.012), lower soft tissue background (p = 0.001), and improved overall scan quality (p = 0.012) in 10, while HEDP was preferred for bone delineation and overall quality in only a single patient. No significant difference in lesion detection was noted.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1980 by the Radiological Society of North America.